Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.
about
Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-AnalysisThe presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.Osteoporosis and cardiovascular disease: an update.Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies.Live Fluorescent Staining Platform for Drug-Screening and Mechanism-Analysis in Zebrafish for Bone Mineralization.
P2860
Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alendronate as an effective tr ...... kidney transplant recipients.
@en
Alendronate as an effective tr ...... kidney transplant recipients.
@nl
type
label
Alendronate as an effective tr ...... kidney transplant recipients.
@en
Alendronate as an effective tr ...... kidney transplant recipients.
@nl
prefLabel
Alendronate as an effective tr ...... kidney transplant recipients.
@en
Alendronate as an effective tr ...... kidney transplant recipients.
@nl
P2093
P2860
P356
P1476
Alendronate as an effective tr ...... kidney transplant recipients.
@en
P2093
Masanori Okamoto
Shintaro Yamanaka
Takashi Shigematsu
Wataru Yoshimoto
P2860
P304
P356
10.1155/2014/269613
P577
2014-02-19T00:00:00Z